BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993;80:1015-1018. [PMID: 8402053 DOI: 10.1002/bjs.1800800829] [Cited by in Crossref: 306] [Cited by in F6Publishing: 266] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Thompson GB. Gastric adenocarcinoma: where are we headed? Hosp Pract (Off Ed) 1995;30:33-40. [PMID: 7822443 DOI: 10.1080/21548331.1995.11443130] [Reference Citation Analysis]
2 Ilhan E, Ureyen O. A Comparison of Subtotal Gastrectomy and Total Gastrectomy for Distal Gastric Cancer. Indian J Surg 2019;81:70-6. [DOI: 10.1007/s12262-018-1834-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hermanek P, Wittekind C. Histological Typing and Grading of Gastric Carcinomas. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, editors. Gastric Cancer. Tokyo: Springer Japan; 1993. pp. 40-52. [DOI: 10.1007/978-4-431-68328-5_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Janjigian YY, Kelsen DP. Genomic Dysregulation in gastric tumors: Genomic Dysregulation in Gastric Tumors. J Surg Oncol 2013;107:237-42. [DOI: 10.1002/jso.23263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
5 Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer: PROGNOSTIC FACTORS IN GASTRIC CANCER. Br J Surg 1997;84:1651-64. [DOI: 10.1046/j.1365-2168.1997.00619.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Ubhi SS, McCulloch P, Veitch PS. Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy. Br J Cancer 1997;76:1667-9. [PMID: 9413960 DOI: 10.1038/bjc.1997.615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kodera Y, Yamamura Y, Nakamura S, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg. 1998;227:45-50. [PMID: 9445109 DOI: 10.1097/00000658-199801000-00007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
8 Lacueva J, Perez-Ramos M, Soto JL, Oliver I, Andrada E, Medrano J, Perez-Vazquez T, Arroyo A, Carrato A, Ferragut JA. Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR. Histopathology. 2005;46:389-395. [PMID: 15810950 DOI: 10.1111/j.1365-2559.2005.02100.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kim AY, Han JK, Seong CK, Kim TK, Choi BI. MRI in staging advanced gastric cancer: is it useful compared with spiral CT? J Comput Assist Tomogr 2000;24:389-94. [PMID: 10864073 DOI: 10.1097/00004728-200005000-00006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
10 Whiting JL, Fielding JW. Radical surgery for early gastric cancer. Eur J Surg Oncol 1998;24:263-6. [PMID: 9724989 DOI: 10.1016/s0748-7983(98)80002-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sivins A, Pedrazzani C, Roviello F, Ancans G, Timofejevs M, Pcholkins A, Krumins V, Boka V, Stengrevics A, Leja M. Surgical treatment of gastric cancer in Latvia: results of centralized experience. Eur J Surg Oncol 2009;35:481-5. [PMID: 19117716 DOI: 10.1016/j.ejso.2008.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Di Leo A, Marrelli D, Roviello F, Bernini M, Minicozzi A, Giacopuzzi S, Pedrazzani C, Baiocchi LG, de Manzoni G. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-1153. [PMID: 17576611 DOI: 10.1007/s11605-006-0062-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
13 Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer 2013;13:136-48. [PMID: 24156033 DOI: 10.5230/jgc.2013.13.3.136] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 8.8] [Reference Citation Analysis]
14 Santos Bdo N, de Oliveira MB, Peixoto RD. Hiatal Hernia as a Total Gastrectomy Complication. Case Rep Oncol 2016;9:100-5. [PMID: 27293395 DOI: 10.1159/000443633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Böttcher K, Stein HJ, Becker K, Etter M, Ott K, Fink U, Werner M, Roder JD, Sendler A, Zimmermann F, Decker T, Kremer M. Magentumoren. In: Roder JD, Stein HJ, Fink U, editors. Therapie gastrointestinaler Tumoren. Berlin: Springer Berlin Heidelberg; 2000. pp. 217-57. [DOI: 10.1007/978-3-642-59659-9_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
16 O�ate-oca�a LF, Cort�s-c�rdenas SA, Aiello-crocifoglio V, Mondrag�-s�nchez R, Ruiz-molina JM. Preoperative Multivariate Prediction of Morbidity After Gastrectomy for Adenocarcinoma. Ann Surg Oncol 2000;7:281-8. [DOI: 10.1007/s10434-000-0281-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
17 Lacueva FJ, Oliver I, Costa D, Calpena R. To perform or not D2 extended lymphadenectomy in patients with gastric cancer in the West. Effectiveness and limits. Clin Transl Oncol 2006;8:139-41. [PMID: 16648110 DOI: 10.1007/s12094-006-0001-4] [Reference Citation Analysis]
18 Lee W, Chen K, Mok Y. Letter to the editor. World J Surg 1995;19:468-9. [DOI: 10.1007/bf00299193] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
19 Calpena R, Javier Lacueva F, Oliver I, Cansado P, Pérez F, Costa D, Compañ AF, Teresa Pérez M. Estado actual del tratamiento multidisciplinario del cáncer gástrico avanzado. Cirugía Española 2003;74:69-76. [DOI: 10.1016/s0009-739x(03)72191-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77-94. [PMID: 11578917 DOI: 10.1016/s1040-8428(00)00131-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
21 Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862-2866. [PMID: 12115373 DOI: 10.1002/cncr.10550] [Cited by in Crossref: 114] [Cited by in F6Publishing: 122] [Article Influence: 5.7] [Reference Citation Analysis]
22 Imano M, Imamoto H, Itoh T, Satou T, Peng YF, Yasuda A, Kato H, Shiraishi O, Shinkai M, Yasuda T, Takeyama Y, Okuno K, Shiozaki H. Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection. J Surg Oncol 2012;105:43-7. [PMID: 21837682 DOI: 10.1002/jso.22065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
23 Andreollo NA, Lopes LR, Coelho Neto JDS. Complicações pós-operatórias após gastrectomia total no câncer gástrico: análise de 300 doentes. ABCD, arq bras cir dig 2011;24:126-30. [DOI: 10.1590/s0102-67202011000200007] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
24 Sendler A, Siewert JR. Individualizing therapy in gastric cancer. Expert Review of Anticancer Therapy 2014;3:457-70. [DOI: 10.1586/14737140.3.4.457] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
25 Farhat S, Coriat R, Audard V, Leblanc S, Prat F, Chaussade S. Is Endoscopic Submucosal Dissection the Option for Early Gastric Cancer Patients with Contraindication to Surgery? Case Rep Gastroenterol. 2010;4:307-312. [PMID: 21060691 DOI: 10.1159/000320629] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Watanabe T, Okumura T, Hirano K, Yamaguchi T, Sekine S, Nagata T, Tsukada K. Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer. Oncol Lett 2017;13:281-8. [PMID: 28123556 DOI: 10.3892/ol.2016.5432] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
27 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Allum WH. Optimal surgery for gastric cancer: is more always better? Recent Results Cancer Res. 2012;196:215-227. [PMID: 23129377 DOI: 10.1007/978-3-642-31629-6_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
29 Choi WH, Kim S, Shen J, Cheong JH, Hyung WJ, Kim YI, Choi SH, Noh SH, Park CI. Prognostic significance of perinodal extension in gastric cancer. J Surg Oncol 2007;95:540-5. [PMID: 17252555 DOI: 10.1002/jso.20734] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
30 Landheer M, Therasse P, van de Velde C. The importance of quality assurance in surgical oncology. European Journal of Surgical Oncology (EJSO) 2002;28:571-602. [DOI: 10.1053/ejso.2002.1255] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
31 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
32 He RB, Chen JQ. Pre-operative chemotherapy for gastric cancer. J Int Med Res 2009;37:1259-66. [PMID: 19930831 DOI: 10.1177/147323000903700501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery. 2002;131:S85-S91. [PMID: 11821792 DOI: 10.1067/msy.2002.119309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
34 Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127-130. [PMID: 9481396 DOI: 10.1016/s0039-6060(98)70248-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
35 Han HS, Kim YW, Yi NJ, Fleischer GD. Laparoscopy-assisted D2 subtotal gastrectomy in early gastric cancer. Surg Laparosc Endosc Percutan Tech. 2003;13:361-365. [PMID: 14712095 DOI: 10.1097/00129689-200312000-00002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
36 Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Lee JH, Kim YS. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res. 2010;162:177-183. [PMID: 20031164 DOI: 10.1016/j.jss.2009.07.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
37 Songun I, van de Velde CJ. Results of completed clinical trials for gastric cancer. Eur J Surg Oncol 1995;21:588-90. [PMID: 8631398 DOI: 10.1016/s0748-7983(95)94918-6] [Reference Citation Analysis]
38 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
39 Ziqiang W, Feng Q, Zhimin C, Miao W, Lian Q, Huaxing L, Peiwu Y. Comparison of laparoscopically assisted and open radical distal gastrectomy with extended lymphadenectomy for gastric cancer management. Surg Endosc. 2006;20:1738-1743. [PMID: 17024529 DOI: 10.1007/s00464-006-0031-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
40 Songun I, Velde CJ. Can Surgical Treatment Results in Gastric Cancer Be Improved? The Oncologist 1996;1:36-40. [DOI: 10.1634/theoncologist.1-1-36] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006;17:1404-1411. [PMID: 16788003 DOI: 10.1093/annonc/mdl133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
42 Lisborg P, Jatzko G, Horn M, Neumann HJ, Müller M, Stettner H, Denk H. Radical surgery (R2 resection) for gastric cancer. A multivariate analysis. Scand J Gastroenterol 1994;29:1024-8. [PMID: 7871368 DOI: 10.3109/00365529409094880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
43 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
44 Marrelli D, Mazzei MA, Pedrazzani C, Di Martino M, Vindigni C, Corso G, Morelli E, Volterrani L, Roviello F. High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: A prospective single-center study. Ann Surg Oncol. 2011;18:2265-2272. [PMID: 21267792 DOI: 10.1245/s10434-010-1541-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
45 Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999;6:46-56. [PMID: 10030415 DOI: 10.1007/s10434-999-0046-z] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 3.8] [Reference Citation Analysis]
46 Köckerling F, Reck T, Gall FP. Extended gastrectomy: who benefits? World J Surg 1995;19:541-5. [PMID: 7676697 DOI: 10.1007/BF00294716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Kostic Z, Cuk V, Bokun R, Ignjatovic D, Usaj-knezevic S, Ignjatovic M. Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma. VSP 2006;63:349-56. [DOI: 10.2298/vsp0604349k] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
48 Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MR, McMahon MJ, Axon AT. Gastric cancer: a curable disease in Britain. BMJ 1993;307:591-6. [PMID: 8401015 DOI: 10.1136/bmj.307.6904.591] [Cited by in Crossref: 169] [Cited by in F6Publishing: 158] [Article Influence: 5.8] [Reference Citation Analysis]
49 Roviello F, Pedrazzani C, Marrelli D, Di Leo A, Caruso S, Giacopuzzi S, Corso G, de Manzoni G. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439-446. [PMID: 20392590 DOI: 10.1016/j.ejso.2010.03.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
50 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2012;1:CD001964. [PMID: 22258947 DOI: 10.1002/14651858.cd001964.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
51 Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., British Society of Gastroenterology., British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23. [PMID: 12049068 DOI: 10.1136/gut.50.90005.v1] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
52 Catarci M, Montemurro LA, Di Cintio A, Ghinassi S, Coppola L, Pinnarelli L, Belardi A, Koch M, Grassi GB. Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution. Updates Surg. 2010;62:89-99. [PMID: 20845010 DOI: 10.1007/s13304-010-0017-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
53 Cuschieri A. Surgical treatment of patients with invasive gastric cancer:dogma, debate and data. European Journal of Surgical Oncology (EJSO) 1999;25:205-8. [DOI: 10.1053/ejso.1998.0628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993;72:2089-97. [PMID: 8374867 DOI: 10.1002/1097-0142(19931001)72:7<2089::aid-cncr2820720706>3.0.co;2-h] [Cited by in Crossref: 228] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
55 Bösing NM, Goretzki PE, Röher HD. Gastric cancer: which patients benefit from systematic lymphadenectomy? Eur J Surg Oncol. 2000;26:498-505. [PMID: 11016473 DOI: 10.1053/ejso.1999.0930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
56 Kim J. Surgical results in gastric cancer. Semin Surg Oncol 1999;17:132-8. [DOI: 10.1002/(sici)1098-2388(199909)17:2<132::aid-ssu8>3.0.co;2-e] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
57 Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30. [PMID: 10188901 DOI: 10.1038/sj.bjc.6690243] [Cited by in Crossref: 937] [Cited by in F6Publishing: 836] [Article Influence: 40.7] [Reference Citation Analysis]
58 Nitti D, Marchet A, Mammano E, Ambrosi A, Belluco C, Mencarelli R, Maino M, Marconato G, Farinati F, Lise M. Extended lymphadenectomy (D2) in patients with early gastric cancer. Eur J Surg Oncol. 2005;31:875-881. [PMID: 16051460 DOI: 10.1016/j.ejso.2005.05.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
59 Deng J, Liang H, Sun D, Pan Y. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res. 2010;161:47-53. [PMID: 19783008 DOI: 10.1016/j.jss.2008.12.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
60 Okajima W, Komatsu S, Ichikawa D, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol 2016;31:1566-71. [PMID: 26840392 DOI: 10.1111/jgh.13306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
61 Gil-rendo A, Hernández-lizoain, Martínez-regueira F, Sierra Martínez A, Rotellar Sastre F, Delgado MC, Azcarate VV, Idoate CP, Álvarez-cienfuegos J. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 2006;8:354-61. [DOI: 10.1007/s12094-006-0182-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
62 Siewert JR, Sendler A. Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res. 2000;157:259-269. [PMID: 10857179 DOI: 10.1007/978-3-642-57151-0_23] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
63 Harrison LE, Karpeh MS, Brennan MF. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg. 1998;2:126-131. [PMID: 9834407 DOI: 10.1016/s1091-255x(98)80002-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
64 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006;93:394-400. [PMID: 16550575 DOI: 10.1002/jso.20495] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
65 Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology. 2013;85:204-207. [PMID: 24051869 DOI: 10.1159/000354736] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
66 Mary F, Zaanan A, Boige V, Artru P, Samalin E, Coriat R, Bachet J, Boubaya M, Benallaoua M, Tougeron D, Afchain P, Locher C, Baumgaertner I, Lecaille C, des Guetz G, Aparicio T. Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study. Digestive and Liver Disease 2016;48:1498-502. [DOI: 10.1016/j.dld.2016.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
67 Nekarda H, Siewert JR, Schmitt M, Ulm K. Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet 1994;343:117. [PMID: 7903748 DOI: 10.1016/s0140-6736(94)90845-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
68 Catarci M, Guadagni S, Zaraca F, Pistoia MA, Mastracchio A, Trecca A, Ruco L, Carboni M. Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Annals of Surgical Oncology 1998;5:580-4. [DOI: 10.1007/bf02303825] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
69 Cozzaglio L, Bottura R, Di Rocco M, Gennari L, Doci R. Sentinel lymph node biopsy in gastric cancer: possible applications and limits. Eur J Surg Oncol. 2011;37:55-59. [PMID: 21115231 DOI: 10.1016/j.ejso.2010.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
70 Bozzetti F. D2 lymphadenectomy (over-D1 dissection) for advanced gastric cancer is an evidence-based procedure. J Gastrointest Surg 2011;15:2122-3. [PMID: 21717280 DOI: 10.1007/s11605-011-1612-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, Coit DG, Brennan MF. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6. [PMID: 20224369 DOI: 10.1097/SLA.0b013e3181d3d29b] [Cited by in Crossref: 227] [Cited by in F6Publishing: 129] [Article Influence: 18.9] [Reference Citation Analysis]
72 Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American Joint Committee on Cancer staging, proximal disease, and the ?different disease? hypothesis. Cancer 2000;88:921-32. [DOI: 10.1002/(sici)1097-0142(20000215)88:4<921::aid-cncr24>3.0.co;2-s] [Cited by in Crossref: 365] [Article Influence: 16.6] [Reference Citation Analysis]
73 de Manzoni G, Verlato G, Roviello F, Morgagni P, Di Leo A, Saragoni L, Marrelli D, Kurihara H, Pasini F. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002;87:171-4. [PMID: 12107838 DOI: 10.1038/sj.bjc.6600432] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 3.3] [Reference Citation Analysis]
74 García I, Del Casar J, Corte M, Allende M, García-muñiz J, Vizoso F. Epidermal Growth Factor Receptor and c-erbB-2 Contents in Unresectable (UICC R1 or R2) Gastric Cancer. Int J Biol Markers 2003;18:200-6. [DOI: 10.1177/172460080301800308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
75 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Lirici MM, Napolitano C, Piro F. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer. Am J Surg. 2004;188:728-735. [PMID: 15619491 DOI: 10.1016/j.amjsurg.2004.08.040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
76 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
77 Imano M, Imamoto H, Itoh T, Satou T, Peng Y, Yasuda A, Kato H, Nishiki K, Shiraishi O, Shinkai M, Tsubaki M, Yasuda T, Nishida S, Takeyama Y, Okuno K, Shiozaki H. Impact of Intraperitoneal Chemotherapy after Gastrectomy with Positive Cytological Findings in Peritoneal Washings. Eur Surg Res 2011;47:254-9. [DOI: 10.1159/000333803] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
78 Ti TK. Radical surgery for gastric cancer in Singapore. Surg Today 1995;25:573-8. [PMID: 7549266 DOI: 10.1007/BF00311428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
79 del Casar JM, Corte MD, Alvarez A, García I, Bongera M, González LO, García-Muñiz JL, Allende MT, Astudillo A, Vizoso FJ. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol 2008;134:153-61. [PMID: 17628829 DOI: 10.1007/s00432-007-0264-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
80 Bozzetti F. Principles of Surgical Radicality in the Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2001;10:833-54. [DOI: 10.1016/s1055-3207(18)30035-8] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
81 Deng J, Liang H. D2 lymphadenectomy in gastric cancer surgery. Clin Oncol Cancer Res 2009;6:162-8. [DOI: 10.1007/s11805-009-0162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, Shimada H, Horiuchi F, Ohki S, Isono K. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today. 1999;29:111-115. [PMID: 10030734 DOI: 10.1007/bf02482234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
83 Janjigian YY, Tang LH, Coit DG, Kelsen DP, Francone TD, Weiser MR, Jhanwar SC, Shah MA. MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1021-1027. [PMID: 21393565 DOI: 10.1158/1055-9965.epi-10-1080] [Cited by in Crossref: 114] [Cited by in F6Publishing: 67] [Article Influence: 10.4] [Reference Citation Analysis]
84 Elias D. Reflections and proposals for the standardization of lymphadenectomy for gastric carcinoma. European Journal of Surgical Oncology (EJSO) 2000;26:6-10. [DOI: 10.1053/ejso.1999.0731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
85 Noguchi M, Miyazaki I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65. [DOI: 10.1002/(sici)1096-9098(199705)65:1<57::aid-jso12>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
86 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
87 Samalin E, Afchain P, Thézenas S, Abbas F, Romano O, Guimbaud R, Bécouarn Y, Desseigne F, Edeline J, Mitry E, Bouché O, Adenis A, Aparicio T, Dorval E, Kramar A, Ychou M. Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment. Clin Res Hepatol Gastroenterol 2011;35:48-54. [PMID: 21634054 DOI: 10.1016/j.gcb.2010.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
88 Maier A, Anegg U, Fell B, Tomaselli F, Sankin O, Prettenhofer U, Pinter H, Rehak P, Friehs GB, Smolle-j�ttner FM. Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction. Lasers Surg Med 2000;26:461-6. [DOI: 10.1002/1096-9101(2000)26:5<461::aid-lsm5>3.0.co;2-t] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Jatzko GR. Eingeladener Kommentar zu: „Chirurgische Therapie des Magenkarzinoms in Österreich-Ergebnisse einer retrospektiven multizentrischen Umfrage“. Acta Chir Austriaca 1997;29:236-7. [DOI: 10.1007/bf02620082] [Reference Citation Analysis]
90 Wang XZ, Zeng ZY, Ye X, Sun J, Zhang ZM, Kang WM. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. World J Gastrointest Oncol 2020; 12(1): 37-53 [PMID: 31966912 DOI: 10.4251/wjgo.v12.i1.37] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
91 Siewert J, Fink U, Sendler A, Becker K, Böttcher K, Feldmann H, Höfler H, Mueller J, Molls M, Nekarda H, Roder J, Stein H. Gastric cancer. Current Problems in Surgery 1997;34:835-939. [DOI: 10.1016/s0011-3840(97)80006-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
92 Macdonald JS, Hundahl S, Smalley SR, O’dea D, Mitchell EP. Gastric Cancer. In: Blanke CD, Rödel C, Talamonti MS, editors. Gastrointestinal Oncology. Berlin: Springer Berlin Heidelberg; 2011. pp. 101-38. [DOI: 10.1007/978-3-642-13306-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Jang HJ, Kim JH, Song HH, Woo KH, Kim M, Kae SH, Lee J, Cho JW, Kang JH, Lee SI. Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sci. 2008;53:399-404. [PMID: 17597403 DOI: 10.1007/s10620-007-9884-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
94 Hölscher AH, Siewert JR, Fink U. Staging Concepts for Gastrointestinal Malignancies: The Importance of Preoperative Locoregional T- and N-Staging. Gastrointestinal Endoscopy Clinics of North America 1995;5:529-36. [DOI: 10.1016/s1052-5157(18)30418-5] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
95 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262:991-998. [PMID: 25563867 DOI: 10.1097/sla.0000000000001040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
96 Sakate Y, Yashiro M, Tanaka H, Sunami T, Kosaka K, Hirakawa K. Usefulness of inhibiting the lymph node metastasis in human gastric carcinoma by B7-1 gene transfection. J Surg Res 2004;122:89-95. [PMID: 15522320 DOI: 10.1016/j.jss.2004.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
97 Siewert JR, B�ttcher K, Stein HJ, Roder JD, Busch R. Problem of proximal third gastric carcinoma. World J Surg 1995;19:523-31. [DOI: 10.1007/bf00294713] [Cited by in Crossref: 68] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
98 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
99 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303-308. [PMID: 15028313 DOI: 10.1016/j.ejso.2003.11.020] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 10.1] [Reference Citation Analysis]
101 Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004;90:1727-32. [PMID: 15150592 DOI: 10.1038/sj.bjc.6601761] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 7.3] [Reference Citation Analysis]
102 Colvin H, Mizushima T, Eguchi H, Takiguchi S, Doki Y, Mori M. Gastroenterological surgery in Japan: The past, the present and the future. Ann Gastroenterol Surg 2017;1:5-10. [PMID: 29863129 DOI: 10.1002/ags3.12008] [Cited by in Crossref: 110] [Cited by in F6Publishing: 83] [Article Influence: 22.0] [Reference Citation Analysis]
103 Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg. 1998;187:597-603. [PMID: 9849732 DOI: 10.1016/s1072-7515(98)00229-4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
104 Roukos D, Marcouizos G, Batsis C, Kappas A, Encke A. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1996;224:108-9. [PMID: 8678611 DOI: 10.1097/00000658-199607000-00022] [Reference Citation Analysis]
105 Lee JS, Douglass HO Jr. D2 dissection for gastric cancer. Surg Oncol 1997;6:215-25. [PMID: 9775408 DOI: 10.1016/s0960-7404(98)00009-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
106 Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Surg Oncol Clin N Am. 2002;11:415-30, xii. [PMID: 12424860 DOI: 10.1016/s1055-3207(02)00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
107 Kuwahara A, Katano M, Nakamura M, Fujimoto K, Miyazaki K, Mori M, Morisaki T. New therapeutic strategy for gastric carcinoma: a two-step evaluation of malignant potential from its molecular biologic and pathologic characteristics. J Surg Oncol 1999;72:142-9. [PMID: 10562360 DOI: 10.1002/(sici)1096-9098(199911)72:3<142::aid-jso6>3.0.co;2-b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
108 Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, Ryu KW, Lee JY, Kook MC. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery. 2014;155:408-416. [PMID: 24287148 DOI: 10.1016/j.surg.2013.08.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
109 Bollschweiler EH, Mönig SP, Hensler K, Baldus SE, Maruyama K, Hölscher AH. Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann Surg Oncol. 2004;11:506-511. [PMID: 15123460 DOI: 10.1245/aso.2004.04.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
110 Shinohara S, Korenaga D, Edagawa A, Koushi K, Itoh S, Kawanaka H, Eguchi D, Kawasaki K, Okuyama T, Ikeda Y, Takenaka K. Significant prognostic factors in patients with Stage IV gastric cancer with special reference to the curability of surgery. Surg Today 2013;43:40-7. [PMID: 22743702 DOI: 10.1007/s00595-012-0230-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
111 Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009;7:11. [PMID: 19173715 DOI: 10.1186/1477-7819-7-11] [Cited by in Crossref: 151] [Cited by in F6Publishing: 98] [Article Influence: 11.6] [Reference Citation Analysis]
112 Lacueva FJ, Calpena R, Medrano J, Teruel A, Mayol MJ, Graells ML, Camarasa MV, Perez-vazquez MT, Ferragut JA. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer 2000;89:21-8. [DOI: 10.1002/1097-0142(20000701)89:1<21::aid-cncr4>3.0.co;2-t] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
113 Lo SS, Wu CW, Hsieh MC, Kuo HS, Lui WY, P’Eng FK. Relationship between age and clinical characteristics of patients with gastric cancer. J Gastroenterol Hepatol. 1996;11:511-514. [PMID: 8792301 DOI: 10.1111/j.1440-1746.1996.tb01693.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
114 Setälä L, Lipponen P, Kosma V, Marin S, Eskelinen M, Syrjänen K, Alhava E. NUCLEAR MORPHOMETRY AS A PREDICTOR OF DISEASE OUTCOME IN GASTRIC CANCER. J Pathol 1997;181:46-50. [DOI: 10.1002/(sici)1096-9896(199701)181:1<46::aid-path716>3.0.co;2-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
115 Lacueva FJ, Calpena R, Medrano J, Teruel A, Mayol MJ, Graells ML, Camarasa MV, Perez-Vazquez MT, Ferragut JA. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer. 2000;89:21-28. [PMID: 10896996 DOI: 10.1002/1097-0142(20000701)89:1%3C21::AID-CNCR4%3E3.0.CO;2-T] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
116 Starling N, Cunningham D. The role of systemic therapy for localised gastric cancer. Annals of Oncology 2006;17:x114-21. [DOI: 10.1093/annonc/mdl248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
117 Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PW, Yao JC, Feig BW. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer. 2008;113:461-469. [PMID: 18553367 DOI: 10.1002/cncr.23572] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
118 Yoon SS, Yang HK. Lymphadenectomy for gastric adenocarcinoma: should west meet east? Oncologist 2009;14:871-82. [PMID: 19738001 DOI: 10.1634/theoncologist.2009-0070] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
119 Faria GR, Pinto-de-Sousa J, Preto JR, Sousa HS, Barbosa JA, Costa-Maia J. Three decades of clinical-pathological trends in gastric cancer: prospective data from a Portuguese hospital. Int J Surg. 2013;11:472-476. [PMID: 23602895 DOI: 10.1016/j.ijsu.2013.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
120 Dexter SP, Martin IG, McMahon MJ. Radical thoracoscopic esophagectomy for cancer. Surg Endosc. 1996;10:147-151. [PMID: 8932617 DOI: 10.1007/bf00188361] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
121 Meyer HJ, J�hne J, Wilke H. Perspectives of surgery and multimodality treatment in gastric carcinoma. J Cancer Res Clin Oncol 1993;119:384-94. [DOI: 10.1007/bf01218419] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
122 Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59-100. [PMID: 12672518 DOI: 10.1016/S1040-8428(02)00160-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
123 Ballesta-Lopez C, Bastida-Vila X, Catarci M, Mato R, Ruggiero R. Laparoscopic Billroth II distal subtotal gastrectomy with gastric stump suspension for gastric malignancies. Am J Surg. 1996;171:289-292. [PMID: 8619470 DOI: 10.1016/s0002-9610(97)89571-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
124 Xu W, Beeharry MK, Liu W, Yan M, Zhu Z. Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine. Biomed Res Int 2016;2016:3923585. [PMID: 28105420 DOI: 10.1155/2016/3923585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
125 Lissens P, Filez L, Aerts R, D'Hoore A, Van Cutsem E, Ectors N, Penninckx F, Kerremans R. Surgery for gastric remnant carcinoma following Billroth II gastrectomy. Eur J Surg Oncol 1997;23:518-21. [PMID: 9484922 DOI: 10.1016/s0748-7983(97)93013-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
126 Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg. 1995;19:184-190. [PMID: 7754621 DOI: 10.1007/bf00308624] [Cited by in Crossref: 127] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
127 Braumann C, Winkler G, Rogalla P, Menenakos C, Jacobi CA. Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case. World J Surg Oncol 2006;4:34. [PMID: 16796759 DOI: 10.1186/1477-7819-4-34] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
128 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 1996;83:156-61. [DOI: 10.1002/bjs.1800830205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
129 Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Hada M. Should systematic lymph node dissection be recommended for gastric cancer? Pro:. European Journal of Cancer 1998;34:1480-3. [DOI: 10.1016/s0959-8049(98)00201-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
130 Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192-197. [PMID: 16837811 DOI: 10.1159/000094537] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
131 Zilberstein B, Mucerino DR, Yagi OK, Ribeiro-Junior U, Lopasso FP, Bresciani C, Jacob CE, Coimbra BG, Cecconello I. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection? Arq Bras Cir Dig 2012;25:161-4. [PMID: 23411804 DOI: 10.1590/s0102-67202012000300005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
132 Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-65. [DOI: 10.1002/jso.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
133 Bozzetti F. Re: reflections and proposals for the standardization of lymphadenectomy for gastric cancer. Eur J Surg Oncol 2000;26:522-3. [PMID: 11016479 DOI: 10.1053/ejso.2000.0937] [Reference Citation Analysis]
134 Hansson LE, Sparén P, Nyrén O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg. 1999;230:162-169. [PMID: 10450729 DOI: 10.1097/00000658-199908000-00005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
135 Imano M, Okuno K. Treatment strategies for gastric cancer patients with peritoneal metastasis. Surg Today. 2014;44:399-404. [PMID: 23677598 DOI: 10.1007/s00595-013-0603-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
136 Dell'aquila Jr NF, Lopasso FP, Falzoni R, Iriya K, Gama-rodrigues J. Prognostic significance of occult lymph node micrometastasis in gastric cancer: a histochemical and immunohistochemical study based on 1997 UICC TNM and 1998 JGCA classifications. ABCD, arq bras cir dig 2008;21:164-9. [DOI: 10.1590/s0102-67202008000400003] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
137 Schmidt-matthiesen A. Do patients really benefit from the extended lymph node dissection for gastric carcinoma Contra:. European Journal of Cancer 1998;34:1483-6. [DOI: 10.1016/s0959-8049(98)00202-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
138 Sharma D, Thakur A, Toppo S, Chandrakar SK. Lymph node counts in indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach. Asian J Surg 2005;28:116-20. [PMID: 15851365 DOI: 10.1016/S1015-9584(09)60274-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
139 Crookes PF, Incarbone R, Peters JH, Engle S, Bremner CG, Demeester TR. A selective therapeutic approach to gastric cancer in a large public hospital. The American Journal of Surgery 1995;170:602-5. [DOI: 10.1016/s0002-9610(99)80024-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
140 Selcukbiricik F, Buyukunal E, Tural D, Ozguroglu M, Demirelli F, Serdengecti S. Clinicopathological features and outcomes of patients with gastric cancer: A single-center experience. World J Gastroenterol 2013; 19(14): 2154-2161 [PMID: 23599641 DOI: 10.3748/wjg.v19.i14.2154] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
141 Maeta M, Yamashiro H, Saito H, Katano K, Kondo A, Tsujitani S, Ikeguchi M, Kaibara N. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery. 1999;125:325-331. [PMID: 10076618 DOI: 10.1016/s0039-6060(99)70244-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
142 Hundahl SA. Gastric Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations. Surgical Oncology Clinics of North America 1996;5:129-44. [DOI: 10.1016/s1055-3207(18)30409-5] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
143 Lawrence W. Extended surgery for gastric cancer: An historical commentary. Cancer 1998;82:429-32. [DOI: 10.1002/(sici)1097-0142(19980201)82:3<429::aid-cncr1>3.0.co;2-k] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
144 Fernández-Frías A, Cansado P, Oliver I, Lacueva J, Costa D, Sánchez A, Rodríguez JM, Merck B, Pérez-Ramos M, Andrada E, González-Brea JL, Calpena R. [Assessment of the fifth edition of the tumor-node-metastasis (TNM) classification for gastric cancer in our setting]. Cir Esp 2005;78:357-61. [PMID: 16420861 DOI: 10.1016/s0009-739x(05)70954-4] [Reference Citation Analysis]
145 Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg. 1997;84:1651-1664. [PMID: 9448610 DOI: 10.1002/bjs.1800841206] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
146 Yoo M, Han HS, Han D. Comparison of the Counts of Station-Specific Lymph Nodes Retrieved in Laparoscopy-Assisted Distal Gastrectomy of Early Experience with Those in Open Distal Gastrectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques 2014;24:777-81. [DOI: 10.1089/lap.2014.0120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
147 Ott K, Lordick F, Blank S, Büchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011;396:743-58. [PMID: 21234760 DOI: 10.1007/s00423-010-0738-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
148 Lacueva, Teruel, Calpena, Medrano, Mayol, Perez‐vazquez, Rufete, Camarasa, Ferragut. Detection of P‐glycoprotein in frozen and paraffin‐embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies. Histopathology 2001;32:328-34. [DOI: 10.1046/j.1365-2559.1998.00381.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
149 Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58. [PMID: 21577089 DOI: 10.1097/sla.0b013e31821d4d75] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 9.4] [Reference Citation Analysis]
150 Mann GB. Gastric cancer. ANZ J Surg 2004;74:827-8. [PMID: 15456421 DOI: 10.1111/j.1445-1433.2004.03240.x] [Reference Citation Analysis]
151 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
152 Hermanek P, Maruyama K, Sobin LH. Stomach Carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, editors. Prognostic Factors in Cancer. Berlin: Springer Berlin Heidelberg; 1995. pp. 47-63. [DOI: 10.1007/978-3-642-79395-0_6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
153 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
154 Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602. [PMID: 19118437 DOI: 10.1245/s10434-008-0271-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
155 Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461. [PMID: 9790335 DOI: 10.1097/00000658-199810000-00002] [Cited by in Crossref: 762] [Cited by in F6Publishing: 697] [Article Influence: 31.8] [Reference Citation Analysis]
156 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
157 Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000;83:986-991. [PMID: 10993643 DOI: 10.1054/bjoc.2000.1427] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.1] [Reference Citation Analysis]
158 Fuchs KH, Thiede A, Engemann R, Deltz E, Stremme O, Hamelmann H. Reconstruction of the food passage after total gastrectomy: randomized trial. World J Surg. 1995;19:698-705; discussion 705-706. [PMID: 7571666 DOI: 10.1007/BF00295908] [Cited by in Crossref: 77] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
159 Sue-Ling H. Radical D2 gastrectomy for cancer. The case of D2 resections. Ann R Coll Surg Engl 2007;89:672-4. [PMID: 17959003 DOI: 10.1308/003588407X209518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
160 Siemerink E, Schaapveld M, Plukker J, Mulder N, Hospers G. Effect of hospital characteristics on outcome of patients with gastric cancer: A population based study in North-East Netherlands. European Journal of Surgical Oncology (EJSO) 2010;36:449-55. [DOI: 10.1016/j.ejso.2010.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
161 Persiani R, Antonacci V, Biondi A, Rausei S, La Greca A, Zoccali M, Ciccoritti L, D'Ugo D. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13-19. [PMID: 18589356 DOI: 10.1016/j.jamcollsurg.2007.12.050] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
162 Lacueva FJ, Calpena R, Medrano J, Oliver I, Carvajal R. Failure to detect early recurrence of gastric cancer. J Clin Gastroenterol 1998;26:219-21. [PMID: 9600374 DOI: 10.1097/00004836-199804000-00015] [Reference Citation Analysis]
163 Sakamoto J, Yasue M. Extensive lymphadenectomy for gastric cancer patients: what can the results of one trial tell us? The Lancet 1995;345:742-3. [DOI: 10.1016/s0140-6736(95)90633-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
164 Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, Alhava EM. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 1996;74:766-72. [PMID: 8795580 DOI: 10.1038/bjc.1996.434] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 2.3] [Reference Citation Analysis]
165 Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 2008;248:721-7. [PMID: 18948798 DOI: 10.1097/SLA.0b013e318185e62e] [Cited by in Crossref: 451] [Cited by in F6Publishing: 248] [Article Influence: 32.2] [Reference Citation Analysis]
166 Zurlo IV, Basso M, Strippoli A, Calegari MA, Orlandi A, Cassano A, Di Salvatore M, Garufi G, Bria E, Tortora G, Barone C, Pozzo C. Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren's Classification in Pan-Cancer Analysis Era? Cancers (Basel) 2020;12:E1749. [PMID: 32630186 DOI: 10.3390/cancers12071749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
167 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237-2246. [PMID: 11147594 DOI: 10.1002/1097-0142(20001201)89:11%3C2237::AID-CNCR12%3E3.0.CO;2-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 Roukos D, Encke A. Effectiveness of extended lymphadenectomy in noncurative gastrectomy. The American Journal of Surgery 1996;172:303-4. [DOI: 10.1016/s0002-9610(96)00273-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
169 Roukos DH, Kappas AM, Encke A. Extensive lymph-node dissection in gastric cancer: is it of therapeutic value? Cancer Treatment Reviews 1996;22:247-52. [DOI: 10.1016/s0305-7372(96)90018-3] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
170 Ychou M, Boige V, Pignon J, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre J, Saint-aubert B, Genève J, Lasser P, Rougier P. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. JCO 2011;29:1715-21. [DOI: 10.1200/jco.2010.33.0597] [Cited by in Crossref: 1046] [Cited by in F6Publishing: 528] [Article Influence: 95.1] [Reference Citation Analysis]
171 Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K. Surgical treatment and outcome for node-negative gastric cancer. Surgery. 1997;121:633-639. [PMID: 9186463 DOI: 10.1016/S0039-6060(97)90051-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
172 Glehen O, Traverse-Glehen A, Peyrat P, François Y, Gérard JP, Vignal J, Gilly FN. [Stomach adenocarcinoma. Evolution of surgical treatment in a series of 350 cases]. Ann Chir. 2000;125:744-751. [PMID: 11105346 DOI: 10.1016/s0003-3944(00)00268-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
173 The Dutch Gastric Cancer Study Group. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567-71. [DOI: 10.1002/bjs.1800841121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
174 Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 2017;43:203-9. [PMID: 27595506 DOI: 10.1016/j.ejso.2016.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
175 Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-7. [PMID: 10791852 DOI: 10.1007/BF02523656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
176 Jatzko GR, Lisborg PH. Justification for endoscopic treatment of subgroups of early gastric cancer. Eur J Surg Oncol 1998;24:266-8. [PMID: 9724990 DOI: 10.1016/s0748-7983(98)80003-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
177 Siewert JR, Roder JD. Invited commentary. World J Surg 1994;18:877-8. [DOI: 10.1007/bf00299092] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
178 Samalin E, Ychou M. Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts? Curr Opin Oncol 2007;19:384-9. [PMID: 17545805 DOI: 10.1097/CCO.0b013e3281a73674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
179 Park SS, Park JM, Kim JH, Kim WB, Lee J, Kim SJ, Kim CS, Mok YJ. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit? J Surg Oncol 2006;94:16-20. [PMID: 16788938 DOI: 10.1002/jso.20560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
180 Alline M, Bertrand MM, Colombo PE, Mourregot A, Rouanet P. [Lymph node dissection: what for? From esophagus to rectum: surgical and lymph node related prognostic factors]. Bull Cancer. 2014;101:368-372. [PMID: 24793629 DOI: 10.1684/bdc.2014.1929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
181 Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M; Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014;101:23-31. [PMID: 24375296 DOI: 10.1002/bjs.9345] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 19.9] [Reference Citation Analysis]
182 Herbreteau E, Jooste V, Hamza S, Lepage C, Faivre J, Bouvier AM. Trends in the management of gastric cancer over a 32-year period: a French population-based study. Gastric Cancer 2015;18:129-37. [PMID: 24488016 DOI: 10.1007/s10120-014-0342-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
183 Hohenberger P, Hünerbein M. Detection and management of advanced gastric cancer. Ann Oncol 1996;7:197-203. [PMID: 8777178 DOI: 10.1093/oxfordjournals.annonc.a010549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
184 Noguchi M, Miyazaki I. Management of lymph node metastases in breast cancer and gastric cancer. J Surg Oncol 1995;60:65-71. [DOI: 10.1002/jso.2930600113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
185 Feng Q, Ge ZZ. Advances in treatment of early gastric cancer by endoscopic submucosal dissection. Shijie Huaren Xiaohua Zazhi 2011; 19(19): 2031-2035 [DOI: 10.11569/wcjd.v19.i19.2031] [Reference Citation Analysis]
186 Theuer CP, Al-kuran R, Akiyama Y, Okumura M, Ziogas A, Carpenter PM. Increased Epithelial Cadherin Expression among Japanese Intestinal-Type Gastric Cancers Compared with Specimens from American Patients of European Descent. The American Surgeon 2006;72:332-8. [DOI: 10.1177/000313480607200412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
187 Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 2010; 16(7): 868-874 [PMID: 20143466 DOI: 10.3748/wjg.v16.i7.868] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
188 Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784. [PMID: 12374661 DOI: 10.1007/bf02574500] [Cited by in Crossref: 173] [Cited by in F6Publishing: 80] [Article Influence: 8.7] [Reference Citation Analysis]
189 Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer 2001;84:64-71. [PMID: 11139315 DOI: 10.1054/bjoc.2000.1548] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
190 Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Okamoto K, Makino I, Nakamura K, Hayashi H, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Fujimura T, Ohta T. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. World J Surg Oncol 2014;12:177. [PMID: 24893606 DOI: 10.1186/1477-7819-12-177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
191 Shah MA. Recent developments in the treatment of gastric carcinoma. Curr Oncol Rep 2002;4:193-201. [DOI: 10.1007/s11912-002-0016-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
192 Mafune K. Surgery for Advanced Gastric Cancer. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 271-86. [DOI: 10.1007/4-431-27713-7_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Roviello F, Piagnerelli R, Ferrara F, Caputo E, Scheiterle M, Marrelli D. Assessing the feasibility of full robotic interaortocaval nodal dissection for locally advanced gastric cancer. Int J Med Robot. 2015;11:218-222. [PMID: 24737464 DOI: 10.1002/rcs.1588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
194 Strobel O, Büchler MW. The problem of the poor control arm in surgical randomized controlled trials. Br J Surg 2013;100:172-3. [PMID: 23180610 DOI: 10.1002/bjs.8998] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
195 Cuschieri A. Laparoscopic gastric resection. Surg Clin North Am. 2000;80:1269-1284, viii. [PMID: 10987035 DOI: 10.1016/s0039-6109(05)70224-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
196 Marshall-Webb M, Bright T, Price T, Thompson SK, Watson DI. Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30:1-7. [PMID: 27878904 DOI: 10.1111/dote.12516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
197 Larsen AC, Frøkjær JB, Fisker RV, Iyer V, Mortensen PB, Yilmaz MK, Møller B, Kristensen SR, Thorlacius-Ussing O. Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors. Thromb Res 2015;135:802-8. [PMID: 25743885 DOI: 10.1016/j.thromres.2015.01.021] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
198 Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates: High Survival Rates for Asians with Gastric Carcinoma. Cancer 2000;89:1883-92. [DOI: 10.1002/1097-0142(20001101)89:9<1883::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
199 Kodera Y, Schwarz RE, Nakao A. Extended lymph node dissection in gastric carcinoma. Journal of the American College of Surgeons 2002;195:855-64. [DOI: 10.1016/s1072-7515(02)01496-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
200 Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM. Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol. 2005;31:393-400. [PMID: 15837046 DOI: 10.1016/j.ejso.2004.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
201 de Manzoni G, Di Leo A, Pedrazzani C, Castaldini G, Borzellino G, Veraldi G, Cordiano C. Intraoperative US staging of T in gastric cancer: Final results of a blind prospective study. J Surg Oncol 2001;78:158-61. [DOI: 10.1002/jso.1141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
202 Guadagni S, Catarci M, de Manzoni G, Kinoshita T. D1 versus D2 dissection for gastric cancer. Lancet 1995;345:1517; author reply 1517-8. [PMID: 7769935 [PMID: 7769935 DOI: 10.1016/s0140-6736(95)91078-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
203 Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today? The Oncologist 1998;3:171-7. [DOI: 10.1634/theoncologist.3-3-171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
204 Capovilla G, Froiio C, Lang H, Berlth F, Grimminger PP. [Complete response after neoadjuvant therapy for gastric cancer: implications for surgery]. Chirurg 2021. [PMID: 34622304 DOI: 10.1007/s00104-021-01516-4] [Reference Citation Analysis]
205 Hundahl SA, Menck HR, Mansour EG, Winchester DP. The National Cancer Data Base report on gastric carcinoma. Cancer 1997;80:2333-41. [PMID: 9404711 DOI: 10.1002/(sici)1097-0142(19971215)80:12<2333::aid-cncr15>3.0.co;2-v] [Cited by in Crossref: 106] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
206 Shimoyama S, Seto Y, Yasuda H, Mafune K, Kaminishi M. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg. 2005;29:58-65. [PMID: 15599744 DOI: 10.1007/s00268-004-7427-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
207 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States?: A comparison of patient survival among three institutions. Cancer 2000;89:2237-46. [DOI: 10.1002/1097-0142(20001201)89:11<2237::aid-cncr12>3.0.co;2-9] [Cited by in Crossref: 120] [Article Influence: 5.5] [Reference Citation Analysis]
208 Taat CW, Van Lanschot JJB, Gouma DJ, Obertop H. Role of Extended Lymph Node Dissection in the Treatment of Gastrointestinal Tumours: A Review of the Literature. Scandinavian Journal of Gastroenterology 2009;30:109-16. [DOI: 10.3109/00365529509090309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
209 Athlin L, Lundskog B, Stenling R, Eriksson S. Local recurrence and long-term survival in patients with gastric cancer—Analysis of possible impact of clinicopathological parameters. European Journal of Surgical Oncology (EJSO) 1995;21:162-7. [DOI: 10.1016/s0748-7983(95)90336-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Powell AG, Hughes DL, Wheat JR, Lewis WG. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. International Journal of Surgery 2016;28:83-90. [DOI: 10.1016/j.ijsu.2016.02.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
211 Nakajima T. Historical Review of Research and Treatment of Gastric Cancer in Japan: Clinical Aspect. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 29-47. [DOI: 10.1007/4-431-27713-7_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience. Ann Surg Oncol 2003;10:1077-85. [DOI: 10.1245/aso.2003.03.520] [Cited by in Crossref: 136] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
213 Kostić Z, Cuk V, Ignjatović M, Usaj-Knezević S. [Early complications following radical surgical treatment of patients with gastric adenocarcinoma]. Vojnosanit Pregl 2006;63:249-56. [PMID: 16605190 DOI: 10.2298/vsp0603249k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
214 Gochi A, Orita K, Fuchimoto S, Tanaka N, Ogawa N. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Br J Cancer 2001;84:443-51. [PMID: 11207036 DOI: 10.1054/bjoc.2000.1599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
215 Thorban S, Böttcher K, Etter M, Roder JD, Busch R, Siewert JR. Prognostic factors in gastric stump carcinoma. Ann Surg. 2000;231:188-194. [PMID: 10674609 DOI: 10.1097/00000658-200002000-00006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
216 Hur H, Park CH. [Surgical treatment of gastric carcinoma]. Korean J Gastroenterol 2009;54:83-98. [PMID: 19696536 DOI: 10.4166/kjg.2009.54.2.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
217 Pereira MA, Ramos MFKP, Dias AR, Yagi OK, Faraj SF, Zilberstein B, Cecconello I, Mello ES, Ribeiro U Jr. DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS. Arq Bras Cir Dig 2017;30:30-4. [PMID: 28489165 DOI: 10.1590/0102-6720201700010009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
218 Costa ML, de Cássia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol 2006;13:843-50. [PMID: 16614885 DOI: 10.1245/ASO.2006.05.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
219 Lawrence W, Horsley Iii JS. Guest editorial: “EXTENDED” lymph node dissections for gastric cancer—Is more better? J Surg Oncol 1996;61:85-9. [DOI: 10.1002/(sici)1096-9098(199602)61:2<85::aid-jso1>3.0.co;2-n] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
220 Kim JP. Current status of surgical treatment of gastric cancer. J Surg Oncol. 2002;79:79-80. [PMID: 11815992 DOI: 10.1002/jso.10050] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
221 Lee WJ, Lee WC, Houng SJ, Shun CT, Houng RL, Lee PH, Chang KJ, Wei TC, Chen KM. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg. 1995;19:707-713. [PMID: 7571667 DOI: 10.1007/bf00295910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
222 Imano M, Yasuda A, Itoh T, Satou T, Peng YF, Kato H, Shinkai M, Tsubaki M, Chiba Y, Yasuda T, Imamoto H, Nishida S, Takeyama Y, Okuno K, Furukawa H, Shiozaki H. Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. J Gastrointest Surg. 2012;16:2190-2196. [PMID: 23099736 DOI: 10.1007/s11605-012-2059-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
223 Karpeh MS, Brennan MF. Gastric Carcinoma. Annals of Surgical Oncology 1998;5:650-6. [DOI: 10.1007/bf02303836] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
224 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
225 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2003;CD001964. [PMID: 14583942 DOI: 10.1002/14651858.cd001964.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
226 Hartgrink HH, Bonenkamp HJ, van de Velde CJ. Influence of Surgery on Outcomes in Gastric Cancer. Surgical Oncology Clinics of North America 2000;9:97-117. [DOI: 10.1016/s1055-3207(18)30171-6] [Cited by in Crossref: 24] [Article Influence: 1.1] [Reference Citation Analysis]
227 Samalin E, Ychou M. Neoadjuvant therapy for gastroesophageal adenocarcinoma. World J Clin Oncol 2016; 7(3): 284-292 [PMID: 27298768 DOI: 10.5306/wjco.v7.i3.284] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
228 Son T, Hyung WJ, Lee JH, Kim YM, Kim HI, An JY, Cheong JH, Noh SH. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer. 2012;118:4687-4693. [PMID: 22415925 DOI: 10.1002/cncr.27426] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
229 Ding YB, Xia TS, Wu JD, Chen GY, Wang S, Xia JG. Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 2012;203:217-221. [PMID: 21803328 DOI: 10.1016/j.amjsurg.2010.10.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
230 Agboola O. Adjuvant treatment in gastric cancer. Cancer Treat Rev. 1994;20:217-240. [PMID: 8020004 DOI: 10.1016/0305-7372(94)90001-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
231 Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A, Klinkhammer-Schalke M. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J Cancer Res Clin Oncol 2017;143:2555-62. [PMID: 28840384 DOI: 10.1007/s00432-017-2508-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
232 Roder JD, Bonenkamp JJ, Craven J, van de Velde CJH, Sasako M, Böttcher K, Stein HJ. Lymphadenectomy for gastric cancer in clinical trials: Update. World J Surg 1995;19:546-53. [DOI: 10.1007/bf00294718] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
233 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: Two open issues in gastric cancer. World J Gastroenterol 2014; 20(14): 3889-3904 [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
234 Díaz de Liaño A, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer 2008;11:96-102. [PMID: 18595016 DOI: 10.1007/s10120-008-0460-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
235 McCulloch P. Gastric cancer. Postgrad Med J 1996;72:450-7. [PMID: 8796206 DOI: 10.1136/pgmj.72.850.450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
236 Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 2004;94:477-82. [PMID: 15297191 DOI: 10.1016/j.ygyno.2004.05.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
237 Persiani R, Rausei S, Antonacci V, Biondi A, Casella F, Ciccoritti L, D’ugo D. Metastatic Lymph Node Ratio: A New Staging System for Gastric Cancer. World J Surg 2009;33:2106-11. [DOI: 10.1007/s00268-009-0157-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
238 Kulig P, Sierzega M, Pietruszka S, Pach R, Kołodziejczyk P, Kulig J, Richter P. Types and implications of abdominal fluid collections following gastric cancer surgery. Acta Chir Belg 2020;120:315-20. [PMID: 31060443 DOI: 10.1080/00015458.2019.1615254] [Reference Citation Analysis]
239 Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol. 2002;28:406-412. [PMID: 12099651 DOI: 10.1053/ejso.2001.1247] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
240 Eom BW, Joo J, Kim Y, Park B, Park JY, Yoon HM, Lee JH, Ryu KW. Is There Any Role of Additional Retropancreatic Lymph Node Dissection on D2 Gastrectomy for Advanced Gastric Cancer? Ann Surg Oncol 2013;20:2669-75. [DOI: 10.1245/s10434-013-2938-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
241 Meyer H, J�hne J. Lymph node dissection for gastric cancer. Semin Surg Oncol 1999;17:117-24. [DOI: 10.1002/(sici)1098-2388(199909)17:2<117::aid-ssu6>3.0.co;2-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Díaz de Liaño A, Yárnoz C, Aguilar R, Artieda C, Ortiz H. [Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit]. Cir Esp 2008;83:18-23. [PMID: 18208744 DOI: 10.1016/s0009-739x(08)70491-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
243 Roy MK, Sadhu S, Dubey SK. Advances in the management of gastric cancer. Indian J Surg. 2009;71:342-349. [PMID: 23133189 DOI: 10.1007/s12262-009-0092-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
244 Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199-206. [PMID: 19142901 DOI: 10.1002/jso.21224] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
245 Roder JD, B�ttcher K, Busch R, Wittekind C, Hermanek P, Siewert JR; German Gastric Cancer Study Group. Classification of regional lymph node metastasis from gastric carcinoma. Cancer 1998;82:621-31. [DOI: 10.1002/(sici)1097-0142(19980215)82:4<621::aid-cncr2>3.0.co;2-o] [Cited by in Crossref: 55] [Article Influence: 2.3] [Reference Citation Analysis]
246 Soyfer V, Corn BW, Melamud A, Alani S, Tempelhof H, Agai R, Shmueli A, Figer A, Kovner F. Three-dimensional non-coplanar conformal radiotherapy yields better results than traditional beam arrangements for adjuvant treatment of gastric cancer. Int J Radiat Oncol Biol Phys 2007;69:364-9. [PMID: 17482375 DOI: 10.1016/j.ijrobp.2007.03.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
247 Griffith JP, Sue-Ling HM, Martin I, Dixon MF, McMahon MJ, Axon AT, Johnston D. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut. 1995;36:684-690. [PMID: 7797117 DOI: 10.1136/gut.36.5.684] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 4.0] [Reference Citation Analysis]
248 Volpe CM, Driscoll DL, Douglass HO. Outcome of Patients With Proximal Gastric Cancer Depends on Extent of Resection and Number of Resected Lymph Nodes. Ann Surg Oncol 2000;7:139-44. [DOI: 10.1007/s10434-000-0139-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
249 Vural V, Saylam B, Çomçalı B, Düzgün AP, Özer MV, Coşkun F. D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications. Ulus Cerrahi Derg 2013;29:1-6. [PMID: 25931833 DOI: 10.5152/UCD.2013.01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
250 Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, van Sandick JW. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013;20:381-98. [PMID: 23054104 DOI: 10.1245/s10434-012-2574-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
251 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
252 Martin RC, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg. 2002;194:568-577. [PMID: 12025834 DOI: 10.1016/s1072-7515(02)01116-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
253 Randjelovic DT, Filipovic RB, Bilanovic LD, Stanisavljevic SN. Perigastric vascular abnormalities and the impact on esophagogastrectomy. Dis Esophagus. 2007;20:390-398. [PMID: 17760652 DOI: 10.1111/j.1442-2050.2007.00633.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
254 Siewert JR. Invited commentary. World J Surg 1995;19:553-553. [DOI: 10.1007/bf00294719] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
255 Tentes AK, Markakidis SK, Karanikiotis C, Fiska A, Tentes IK, Manolopoulos VG, Dimitriou T. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer. Langenbecks Arch Surg 2006;391:124-9. [DOI: 10.1007/s00423-006-0022-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
256 Sunami T, Yashiro M, Chung KH. ICAM-1 (intercellular adhesion molecule-1) gene transfection inhibits lymph node metastasis by human gastric cancer cells. Jpn J Cancer Res. 2000;91:925-933. [PMID: 11011121 DOI: 10.1111/j.1349-7006.2000.tb01036.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
257 Suzuki T, Ochiai T, Hayashi H, Hori S, Shimada H, Isono K. Peritoneal lavage cytology findings as prognostic factor for gastric cancer. Semin Surg Oncol 1999;17:103-7. [DOI: 10.1002/(sici)1098-2388(199909)17:2<103::aid-ssu4>3.0.co;2-q] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
258 Wang JY, Lin SR, Lu CY, Chen CC, Wu DC, Chai CY, Chen FM, Hsieh JS, Huang TJ. Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Lett. 2005;223:129-135. [PMID: 15890245 DOI: 10.1016/j.canlet.2004.09.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
259 Snyder RA, Castaldo ET, Bailey CE, Phillips SE, Chakravarthy AB, Merchant NB. Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Int J Surg Oncol. 2012;2012:307670. [PMID: 22778937 DOI: 10.1155/2012/307670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
260 Kong JH, Lee J, Yi CA, Park SH, Park JO, Park YS, Lim HY, Park KW, Kang WK. Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome. Gastric Cancer. 2012;15:292-298. [PMID: 22037917 DOI: 10.1007/s10120-011-0104-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
261 Roukos D, Schmidt-Mathiesen A, Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol 1995;4:323-32. [PMID: 8809955 DOI: 10.1016/s0960-7404(10)80045-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
262 Ozmen MM, Ozmen F, Zulfikaroglu B. Lymph nodes in gastric cancer. J Surg Oncol 2008;98:476-81. [DOI: 10.1002/jso.21134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
263 Elias D. Reflections and proposals for the worldwide standardization of lymphadenectomy for gastric carcinoma. J Surg Oncol 1999;71:120-2. [PMID: 10389870 DOI: 10.1002/(sici)1096-9098(199906)71:2<120::aid-jso12>3.0.co;2-i] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
264 Guadagni S, Gola P, Marsili L, Catarci M, Mancini E, Agnifili A, De Bernardinis G, Sano T, Maruyama K. Arterial vasculature of the stomach and oncologic gastrectomies. Surg Radiol Anat 1995;17:269-76. [PMID: 7502193 DOI: 10.1007/BF01795062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
265 Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900-911. [PMID: 21394009 DOI: 10.1097/sla.0b013e318212bff6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
266 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer: LYMPH NODE METASTASIS IN GASTRIC CANCER. Br J Surg 1996;83:156-61. [DOI: 10.1046/j.1365-2168.1996.02183.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
267 Fink U, Stein HJ, Schuhmacher C, Wilke HJ. Neoadjuvant chemotherapy for gastric cancer: update. World J Surg. 1995;19:509-516. [PMID: 7676692 DOI: 10.1007/bf00294711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
268 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
269 Homann N, Pauligk C, Luley K, Werner Kraus T, Bruch HP, Atmaca A, Noack F, Altmannsberger HM, Jäger E, Al-Batran SE. Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel. Int J Cancer 2012;130:1706-13. [PMID: 21618509 DOI: 10.1002/ijc.26180] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
270 Cook JA, Ramsaya CR, Fayers P. Statistical evaluation of learning curve effects in surgical trials. Clinical Trials 2004;1:421-7. [DOI: 10.1191/1740774504cn042oa] [Cited by in Crossref: 128] [Cited by in F6Publishing: 117] [Article Influence: 21.3] [Reference Citation Analysis]
271 Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kido Y, Kasaoka C. Progressive improvement of prognosis for patients with gastric cancer (dynamic stage grouping) with increasing survival interval from initial staging: how much longer can a given survivor expect to live? Surgery 2003;133:135-40. [PMID: 12605173 DOI: 10.1067/msy.2003.95] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
272 Schimanski CC, Schlaegel F, Jordan M, Moehler M, Sgourakis G, Drescher DG, Galle PR, Lang H, Gockel I. VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. World J Surg 2011;35:1010-6. [PMID: 21387130 DOI: 10.1007/s00268-011-1041-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
273 Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, Fraker DL, Karakousis GC, Roses RE. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer. 2014;120:2855-2865. [PMID: 24854027 DOI: 10.1002/cncr.28780] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]